DRW is committed to tackling some of the world’s most serious infectious diseases by making
widely available breakthrough point-of care diagnostics developed in
the Diagnostic Development Unit of Cambridge University. Its
signal amplification technologies offer rapid and reliable tests for
Chlamydia, Hepatitis and HIV. DRW is currently focused on providing
rapid Early Infant Diagnosis (EID) as well as Viral Load (VL)
measurement for those living with HIV, thereby enabling test-and-treat
facility in even the most challenging and resource-limited environments.